1/13/25 07:00 | 1/10/25 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 21 | 2.08 | 0 | 10 | 2 | 660 | D | | | | | | | | | | | | | | |
7/1/24 16:30 | 7/1/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 100 | 5.33 | 0 | 19 | 3 | 650 | D | | | | | | | | | | | | | | |
6/20/24 08:30 | 6/18/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 30 | 2.08 | 0 | 14 | 2 | 631 | D | | | | | | | | | | | | | | |
1/2/24 17:43 | 1/2/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 19 | 2.08 | 0 | 9 | 1 | 616 | D | | | | | | | | | | | | | | |
11/6/23 18:00 | 11/3/23 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 42 | 2.08 | 0 | 20 | 3 | 607 | D | | | | | | | | | | | | | | |
8/8/23 16:30 | 8/8/23 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 25 | 2.08 | 0 | 12 | 2 | 587 | D | | | | | | | | | | | | | | |
12/8/22 18:11 | 12/8/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 21 | 2.08 | 0 | 10 | 2 | 574 | D | | | | | | | | | | | | | | |
10/17/22 20:09 | 10/17/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 124 | 2.08 | 0 | 60 | 12 | 562 | D | | | | | | | | | | | | | | |
5/3/22 19:27 | 5/3/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 42 | 2.08 | 0 | 20 | 4 | 502 | D | | | | | | | | | | | | | | |
1/14/22 17:30 | 1/14/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 21 | 2.08 | 0 | 10 | 2 | 482 | D | | | | | | | | | | | | | | |
1/12/22 19:30 | 1/10/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.dm | 100 | 2.08 | 0 | 48 | 11 | 472 | D | | | | | | | | | | | | | | |
1/12/22 19:30 | 1/10/22 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.dm | -2,559 | 53.31 | 0 | -48 | -9 | 472 | D | | | | | | | | | | | | | | |
12/16/21 16:49 | 12/16/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 17 | 2.08 | 0 | 8 | 2 | 472 | D | | | | | | | | | | | | | | |
10/12/21 16:30 | 10/8/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.dm | 100 | 2.08 | 0 | 48 | 12 | 464 | D | | | | | | | | | | | | | | |
10/12/21 16:30 | 10/8/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.dm | -2,705 | 56.34 | 0 | -48 | -9 | 464 | D | | | | | | | | | | | | | | |
8/19/21 16:30 | 8/19/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 25 | 2.08 | 0 | 12 | 3 | 464 | D | | | | | | | | | | | | | | |
8/5/21 16:14 | 8/3/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.dm | 14 | 2.08 | 0 | 7 | 2 | 452 | D | | | | | | | | | | | | | | |
8/5/21 16:14 | 8/3/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.dm | -403 | 60.06 | 0 | -7 | -1 | 452 | D | | | | | | | | | | | | | | |
8/2/21 17:53 | 7/29/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.dm | 63 | 2.08 | 0 | 30 | 7 | 452 | D | | | | | | | | | | | | | | |
8/2/21 17:53 | 7/29/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.dm | -1,832 | 60.25 | 0 | -30 | -6 | 452 | D | | | | | | | | | | | | | | |
7/28/21 16:57 | 7/26/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.dm | 27 | 2.08 | 0 | 13 | 3 | 452 | D | | | | | | | | | | | | | | |
7/28/21 16:57 | 7/26/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.dm | -775 | 60.15 | 0 | -13 | -3 | 452 | D | | | | | | | | | | | | | | |
7/9/21 16:30 | 7/8/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 100 | 2.08 | 0 | 48 | 12 | 452 | D | | | | | | | | | | | | | | |
7/9/21 16:30 | 7/8/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.d | -2,386 | 49.70 | 0 | -48 | -10 | 452 | D | | | | | | | | | | | | | | |
6/14/21 17:57 | 6/14/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 83 | 2.08 | 0 | 40 | 10 | 452 | D | | | | | | | | | | | | | | |
6/11/21 16:15 | 6/10/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 48 | 2.08 | 0 | 23 | 6 | 412 | D | | | | | | | | | | | | | | |
6/11/21 16:15 | 6/10/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.d | -1,182 | 51.38 | 0 | -23 | -5 | 412 | D | | | | | | | | | | | | | | |
6/9/21 17:54 | 6/7/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.dm | 39 | 2.08 | 0 | 19 | 5 | 412 | D | | | | | | | | | | | | | | |
6/9/21 17:54 | 6/7/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.dm | -939 | 50.10 | 0 | -19 | -4 | 412 | D | | | | | | | | | | | | | | |
5/19/21 17:56 | 5/19/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 31 | 2.08 | 0 | 15 | 4 | 412 | D | | | | | | | | | | | | | | |
5/14/21 17:20 | 5/12/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 17 | 2.08 | 0 | 8 | 2 | 397 | D | | | | | | | | | | | | | | |
5/14/21 17:20 | 5/12/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.d | -413 | 50.05 | 0 | -8 | -2 | 397 | D | | | | | | | | | | | | | | |
4/26/21 17:15 | 4/22/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.dm | 30 | 2.08 | 0 | 14 | 4 | 397 | D | | | | | | | | | | | | | | |
4/26/21 17:15 | 4/22/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.dm | -580 | 40.23 | 0 | -14 | -4 | 397 | D | | | | | | | | | | | | | | |
4/19/21 19:12 | 4/15/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.dm | 24 | 2.08 | 0 | 12 | 3 | 397 | D | | | | | | | | | | | | | | |
4/19/21 19:12 | 4/15/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.dm | -225 | 40.26 | 0 | -6 | -1 | 397 | D | | | | | | | | | | | | | | |
4/13/21 18:39 | 4/13/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.d | 31 | 2.08 | 0 | 15 | 4 | 391 | D | | | | | | | | | | | | | | |
4/12/21 18:11 | 4/8/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | M.dm | 100 | 2.08 | 0 | 48 | 15 | 376 | D | | | | | | | | | | | | | | |
4/12/21 18:11 | 4/8/21 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Mainolfi Nello | MA | DO | CEO | S.dm | -1,614 | 33.62 | 0 | -48 | -11 | 376 | D | | | | | | | | | | | | | | |